| Conserved role of intragenic DNA methylation in regulating alternative promoters AK Maunakea, RP Nagarajan, M Bilenky, TJ Ballinger, C D’Souza, ... Nature 466 (7303), 253-257, 2010 | 1960 | 2010 |
| Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer Q Wang, W Li, Y Zhang, X Yuan, K Xu, J Yu, Z Chen, R Beroukhim, ... Cell 138 (2), 245-256, 2009 | 1074 | 2009 |
| Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer T Migita, S Ruiz, A Fornari, M Fiorentino, C Priolo, G Zadra, F Inazuka, ... Journal of the National Cancer Institute 101 (7), 519-532, 2009 | 435 | 2009 |
| High-throughput functional testing of ENCODE segmentation predictions JC Kwasnieski, C Fiore, HG Chaudhari, BA Cohen Genome research 24 (10), 1595-1602, 2014 | 270 | 2014 |
| ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer C Cai, H Wang, HH He, S Chen, L He, F Ma, L Mucci, Q Wang, C Fiore, ... The Journal of clinical investigation 123 (3), 1109-1122, 2013 | 193 | 2013 |
| Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy ME Beaulieu, T Jauset, D Massó-Vallés, S Martínez-Martín, P Rahl, ... Science translational medicine 11 (484), eaar5012, 2019 | 189 | 2019 |
| Vitamin D receptor protein expression in tumor tissue and prostate cancer progression WK Hendrickson, R Flavin, JL Kasperzyk, M Fiorentino, F Fang, R Lis, ... Journal of clinical oncology 29 (17), 2378, 2011 | 169 | 2011 |
| Overexpression of fatty acid synthase is associated with palmitoylation of Wnt1 and cytoplasmic stabilization of β-catenin in prostate cancer M Fiorentino, G Zadra, E Palescandolo, G Fedele, D Bailey, C Fiore, ... Laboratory investigation 88 (12), 1340-1348, 2008 | 152 | 2008 |
| Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survival PL Nguyen, J Ma, JE Chavarro, ML Freedman, R Lis, G Fedele, C Fiore, ... Journal of Clinical Oncology 28 (25), 3958, 2010 | 146 | 2010 |
| Superenhancer analysis defines novel epigenomic subtypes of non-APL AML, including an RARα dependency targetable by SY-1425, a potent and selective RARα agonist MR McKeown, MR Corces, ML Eaton, C Fiore, E Lee, JT Lopez, ... Cancer discovery 7 (10), 1136-1153, 2017 | 135 | 2017 |
| Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARDependency Targetable by SY-1425, a Potent and Selective RARAgonist MR McKeown, MR Corces, ML Eaton, C Fiore, E Lee, JT Lopez, ... | 135 | 2017 |
| c‐Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme EL Snyder, DJ Sandstrom, K Law, C Fiore, E Sicinska, J Brito, D Bailey, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2009 | 90 | 2009 |
| SPINK1 protein expression and prostate cancer progression R Flavin, A Pettersson, WK Hendrickson, M Fiorentino, S Finn, L Kunz, ... Clinical Cancer Research 20 (18), 4904-4911, 2014 | 83 | 2014 |
| Functional cis-regulatory modules encoded by mouse-specific endogenous retrovirus V Sundaram, MNK Choudhary, E Pehrsson, X Xing, C Fiore, M Pandey, ... Nature communications 8 (1), 1-12, 2017 | 77 | 2017 |
| Utility of multispectral imaging in automated quantitative scoring of immunohistochemistry C Fiore, D Bailey, N Conlon, X Wu, N Martin, M Fiorentino, S Finn, K Fall, ... Journal of clinical pathology 65 (6), 496-502, 2012 | 68 | 2012 |
| Interactions between pluripotency factors specify cis-regulation in embryonic stem cells C Fiore, BA Cohen Genome research 26 (6), 778-786, 2016 | 47 | 2016 |
| Model-based transcriptome engineering promotes a fermentative transcriptional state in yeast DG Michael, EJ Maier, H Brown, SR Gish, C Fiore, RH Brown, MR Brent Proceedings of the National Academy of Sciences 113 (47), E7428-E7437, 2016 | 40 | 2016 |
| Immunohistochemical expression of BRCA1 and lethal prostate cancer M Fiorentino, G Judson, K Penney, R Flavin, J Stark, C Fiore, K Fall, ... Cancer research 70 (8), 3136-3139, 2010 | 33 | 2010 |
| Antitumor synergy with SY-1425, a selective RARα agonist, and hypomethylating agents in retinoic acid receptor pathway activated models of acute myeloid leukemia MR McKeown, L Johannessen, E Lee, C Fiore, E di Tomaso haematologica 104 (4), e138, 2019 | 17 | 2019 |
| Methods of stratifying patients for treatment with retinoic acid receptor-α agonists MR McKeown, C Fiore, ML Eaton, EP Lee, C Fritz US Patent 9,868,994, 2018 | 7 | 2018 |
